Skip to main content
Clinical Trials/NCT06485765
NCT06485765
Completed
Not Applicable

The Effect of the DASH (Dietary Approaches to Stop Hypertension) Diet on Quality of Life and Cardiac Parameters in Patients Acute Coronary Syndrome With Hypertension

Bandırma Onyedi Eylül University1 site in 1 country34 target enrollmentJune 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Coronary Syndrome
Sponsor
Bandırma Onyedi Eylül University
Enrollment
34
Locations
1
Primary Endpoint
Ejection Fraction (%)
Status
Completed
Last Updated
last year

Overview

Brief Summary

The clinical trail study aimed to determine effect of DASH eating plan on cardiac parameters and quality of life in hypertensive individuals diagnosed with acute coronary syndrome.

The main questions it aims to answer are:

  1. DASH diet improve quality of life?
  2. DASH diet improve cardiac parameters?

The researchers assessed the results of 12 weeks of the DASH diet.

Patients will apply the DASH diet prepared individually by the researchers for 12 weeks.

Detailed Description

The study period was 12 weeks. Patients' food consumption (3 day), anthropometric measurements, blood pressure measurements, physical activity levels, biochemical and cardiac parameters, adherence to DASH eating plan and the MacNew Heart Health-Related Quality of Life Scale were recorded at the beginning of the study and at the end of 12 weeks.

Registry
clinicaltrials.gov
Start Date
June 1, 2020
End Date
September 1, 2021
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Bandırma Onyedi Eylül University
Responsible Party
Principal Investigator
Principal Investigator

Hacı Ömer YILMAZ

Assistant Professor (PhD)

Bandırma Onyedi Eylül University

Eligibility Criteria

Inclusion Criteria

  • diagnosed with acute coronary syndrome within the last month
  • with a measured blood pressure above 140/90 mmHg or using antihypertensive drugs
  • not obese (body mass index \< 30)
  • not diagnosed with a disease requiring a different medical nutrition therapy (chronic renal failure, diabetes, cancer, etc.)
  • volunteered to participate in the study

Exclusion Criteria

  • Acute coronary syndrome diagnosed more than 1 month ago
  • obese (body mass index \> 30 )
  • without hypertension
  • receiving different medical nutrition therapy

Outcomes

Primary Outcomes

Ejection Fraction (%)

Time Frame: 12 weeks

A measurement of the percentage of blood leaving the heart each time it squeezes (using echocardiographic imaging)

Quality of Life (MacNew Heart Disease Health-Related Quality of Life Scale)

Time Frame: 12 week

The quality of life of the patients at the beginning of the study and at the end of the 12th week was assessed with the MacNew Heart Disease Health-Related Quality of Life Scale. The scale is a different form of the Post-MI Quality of Life Scale, which was developed to determine especially depression and anxiety in patients with acute MI (Myocardial Infarction) and which can be evaluated by patients responding to the scale. The scale can be used in different cardiac patients such as MI, angina pectoris and heart failure patients and there is a high correlation between it and other tools that assess quality of life. MacNew Heart Disease Health-Related Quality of Life Scale consists of three sub-dimensions (emotional, physical and social) and 27 items in 7-point Likert type. The answer to each item is between 1-7. A low score indicates poor quality of life, while a high score indicates better quality of life.

Study Sites (1)

Loading locations...

Similar Trials